Compile Data Set for Download or QSAR
Report error Found 90 Enz. Inhib. hit(s) with all data for entry = 7639
TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207920(US9266832, Cpd077)
Affinity DataEC50:  17nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207933(US9266832, Cpd090)
Affinity DataEC50:  91nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207932(US9266832, Cpd089)
Affinity DataEC50:  98nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207930(US9266832, Cpd087)
Affinity DataEC50:  133nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207929(US9266832, Cpd086)
Affinity DataEC50:  151nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207928(US9266832, Cpd085)
Affinity DataEC50:  117nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207891(US9266832, Cpd084 | US9266832, Cpd048)
Affinity DataEC50:  26nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207926(US9266832, Cpd083)
Affinity DataEC50:  56nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207925(US9266832, Cpd082)
Affinity DataEC50:  112nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207924(US9266832, Cpd081)
Affinity DataEC50:  23nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207923(US9266832, Cpd080)
Affinity DataEC50:  18nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207922(US9266832, Cpd079)
Affinity DataEC50:  81nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207934(US9266832, Cpd091)
Affinity DataEC50:  581nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207919(US9266832, Cpd076)
Affinity DataEC50:  29nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207918(US9266832, Cpd075)
Affinity DataEC50:  30nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207916(US9266832, Cpd073)
Affinity DataEC50:  242nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207915(US9266832, Cpd072)
Affinity DataEC50:  132nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207914(US9266832, Cpd071)
Affinity DataEC50:  277nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207912(US9266832, Cpd069)
Affinity DataEC50:  90nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207911(US9266832, Cpd068)
Affinity DataEC50:  148nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207910(US9266832, Cpd067)
Affinity DataEC50:  111nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207909(US9266832, Cpd066)
Affinity DataEC50:  386nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207908(US9266832, Cpd065)
Affinity DataEC50:  174nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207945(US9266832, Cpd102)
Affinity DataEC50:  49nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207960(US9266832, Cpd117)
Affinity DataEC50:  109nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207959(US9266832, Cpd116)
Affinity DataEC50:  166nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207958(US9266832, Cpd115)
Affinity DataEC50:  75nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207954(US9266832, Cpd111)
Affinity DataEC50:  537nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207951(US9266832, Cpd108)
Affinity DataEC50:  320nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207950(US9266832, Cpd107)
Affinity DataEC50:  26nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207949(US9266832, Cpd106)
Affinity DataEC50:  82nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207948(US9266832, Cpd105)
Affinity DataEC50:  112nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207947(US9266832, Cpd104)
Affinity DataEC50:  264nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207946(US9266832, Cpd103)
Affinity DataEC50:  139nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207907(US9266832, Cpd064)
Affinity DataEC50:  122nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207944(US9266832, Cpd101)
Affinity DataEC50:  1.05E+3nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207943(US9266832, Cpd100)
Affinity DataEC50:  44nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207942(US9266832, Cpd099)
Affinity DataEC50:  27nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207941(US9266832, Cpd098)
Affinity DataEC50:  535nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207940(US9266832, Cpd097)
Affinity DataEC50:  270nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207939(US9266832, Cpd096)
Affinity DataEC50:  470nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207938(US9266832, Cpd095)
Affinity DataEC50:  241nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207937(US9266832, Cpd094)
Affinity DataEC50:  161nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207936(US9266832, Cpd093)
Affinity DataEC50:  293nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207935(US9266832, Cpd092)
Affinity DataEC50:  76nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207869(US9266832, Cpd026)
Affinity DataEC50:  83nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207881(US9266832, Cpd038)
Affinity DataEC50:  31nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207880(US9266832, Cpd037)
Affinity DataEC50:  32nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207879(US9266832, Cpd036)
Affinity DataEC50:  40nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetAlpha-synuclein(Human)
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207878(US9266832, Cpd035)
Affinity DataEC50:  60nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

Displayed 1 to 50 (of 90 total ) | Next | Last >>
Jump to: